Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction-Reference-Cited by-同舟云学术

Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction

Published:2016-10 Issue: Volume:221 Page:321-326
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kiyokuni Masayoshi,Konishi Masaaki^ORCID,Sakamaki Kentaro,Kawashima Chika,Narikawa Masatoshi^ORCID,Doi Hiroshi,Iwata Kiwamu,Tomari Sakie,Nakayama Naoki,Komura Naohiro^ORCID,Mitsuhashi Takayuki,Yano Hideto,Sugano Teruyasu,Ishigami Tomoaki,Endo Tsutomu,Ishikawa Toshiyuki,Yamanaka Takeharu,Kimura Kazuo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

2. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction);Pizarro;J. Am. Coll. Cardiol.,2014

3. Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function;Garcia-Ruiz;J. Am. Coll. Cardiol.,2016

4. The role of the new beta-blockers in treating cardiovascular disease;Weber;Am. J. Hypertens.,2005

5. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101;Iguchi;Chem. Pharm. Bull.(Tokyo),1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation;Pharmaceutics;2024-04-08

2. Optimal use of intravenous landiolol in acute cardiac care;Expert Review of Cardiovascular Therapy;2023-11-02

3. Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials;Cardiovascular Drugs and Therapy;2023-04-01

4. A landiolol alkalmazási lehetőségei a kardiológiai és intenzív terápiás ellátásban;Orvosi Hetilap;2022-01-09

5. Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention;Heart and Vessels;2020-06-12